Nathan B. Fountain - 06 Jul 2021 Form 4 Insider Report for Acumen Pharmaceuticals, Inc. (ABOS)

Role
Director
Signature
/s/ Katherine Denby, Attorney-in-Fact
Issuer symbol
ABOS
Transactions as of
06 Jul 2021
Net transactions value
+$100,000
Form type
4
Filing time
08 Jul 2021, 18:13:38 UTC
Previous filing
30 Jun 2021
Next filing
17 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABOS Common Stock Purchase $100,000 +6,250 $16.00 6,250 06 Jul 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.